We observed a significant increase in the overall infiltration of immune cells (CD45+) in mice treated with either Delta-24-ACT alone or the combination compared with the mock-treated group (p=0.017 and p=0.0006, respectively, figure 6A gated in online supplemental figure 6B), which demonstrated that these treatments promote immune cell infiltration within the tumor. The gene discussed is PTPRC; the disease is neoplasm.